Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Events
Upcoming events
-
14 Dec
DNB Nordic Healthcare Conference
Camurus is presenting at this conference in Oslo, Norway, 14 December, 2023. More information to come closer to the event.
-
08 Jan
SEB Nordic Seminar
Camurus’ Chief Business Development Officer Fredrik Joabsson is presenting at this conference in Copenhagen, 8 January at 2.00-2.40pm CET. The presentation can be seen by the conference participants.
-
15 Feb
Full Year Report 2023
The full year report 2023 is published on 15 February 2024.
Latest financial report
Camurus’ Interim Report Third Quarter 2023
9 November 2023
Annual General Meeting
Camurus’ Annual General Meeting 2024 will be held on Wednesday, 8 May 2024 at Elite Hotel Ideon in Lund, Sweden.
Shareholders who wish to have a matter dealt with at the AGM should, to ensure that the request can be considered, send such request to the Board of Directors (at the company’s address) no later than on 20 March 2024.
See more information on Camurus' general meetings
See documents from previous Ageneral meetings
Pipeline
Diversified pipeline with large potential
Camurus' innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
